Welcome
Support Centre
06 September 2010 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
A multicentre phase III randomised controlled study of Theratope vaccine for metastatic breast cancer
ISRCTN ISRCTN91516565
ClinicalTrials.gov identifier
Public title A multicentre phase III randomised controlled study of Theratope vaccine for metastatic breast cancer
Scientific title
Acronym N/A
Serial number at source C136
Study hypothesis Not provided at time of registration
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Breast
Participants - inclusion criteria 1. Must have received 4-8 cycles or 12-24 weeks duration of first line chemotherapy for metastatic disease
2. Has either no evidence of disease of non-progressive disease following first line chemotherapy or stable disease
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/01/2000
Anticipated end date 31/12/2005
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions 1. Theratope s/c injections 100 mg with detox at weeks 0, 2, 5 and 9
2. Control injection Keyhole limpet heamocyanin 100 mg with detox at weeks 0, 2, 5 and 9
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding Cancer organisations
Trial website
Publications
Contact name Dr  -  -
  Address UKCCCR Register Co-ordinator
MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email register@ctu.mrc.ac.uk
Sponsor UK Co-ordinating Committee for Cancer Research (UKCCCR)
  Address MRC Clinical Trials Unit
222 Euston Road
  City/town London
  Zip/Postcode NW1 2DA
  Country United Kingdom
  Tel +44 (0) 20 7670 4723
  Fax +44 (0) 20 7670 4818
  Email
Date applied 19/08/2002
Last edited 14/05/2008
Date ISRCTN assigned 19/08/2002
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2010 ISRCTN unless otherwise stated.


BioMed Central